The trial teams in Tübingen, Hirakata, Bern and Oslo randomised one new patient each today. Many thanks and congratulations on this great achievement!
The trial teams in Tübingen, Hirakata, Bern and Oslo randomised one new patient each today. Many thanks and congratulations on this great achievement!